Other data made unavailable through NHIRD restrictions include patient genotype and symptom severity (e.g. degree of intellectual disability), which may have helped elucidate or corroborate past literature; and prescriptions or examinations ordered in the outpatient setting (e.g. medication or radiographic scans), which may have helped to determine the effect of anticonvulsants or mTOR inhibitors on moderating mortality. The gene discussed is MTOR; the disease is Intellectual disability.